FDA Clearance Tracker · P130001-S001
Epi proColon
Last checked: Nov 20, 2026Latest source record: Nov 18, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Nov 18, 2016
Approved
Time to decision
203 days
Received Apr 29, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P130001-S001
- Device name
- Epi proColon
- Applicant
- New Day Diagnostics, LLC
- Applicant location
- Knoxville, TN
- Received
- Apr 29, 2016
- Decided
- Nov 18, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P130001
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Sentinel CH. SpA, Via Robert Koch, 2, 20152, Milan, Italy
Source documents
Other decisions for New Day Diagnostics, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Epi proColonPMA
P130001 · Decided Apr 12, 2016 · 1,195 days after receipt
Device type: System, colorectal neoplasia, DNA methylation and hemoglobin detection (PHP) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.